These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 23390011)
21. Analgesic effects of prostaglandin E2 receptor subtype EP1 receptor antagonist: experimental study of application of nucleus pulposus. Sekiguchi M; Otoshi K; Kikuchi S; Konno S Spine (Phila Pa 1976); 2011 Oct; 36(22):1829-34. PubMed ID: 21270690 [TBL] [Abstract][Full Text] [Related]
22. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease. Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036 [TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells. Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670 [TBL] [Abstract][Full Text] [Related]
24. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells]. Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689 [TBL] [Abstract][Full Text] [Related]
25. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality. Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397 [TBL] [Abstract][Full Text] [Related]
26. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy. Liu A; Hu P; Khawli LA; Epstein AL Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313 [TBL] [Abstract][Full Text] [Related]
27. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response. Adris S; Klein S; Jasnis M; Chuluyan E; Ledda M; Bravo A; Carbone C; Chernajovsky Y; Podhajcer O Gene Ther; 1999 Oct; 6(10):1705-12. PubMed ID: 10516719 [TBL] [Abstract][Full Text] [Related]
28. CC chemokine ligand 21 enhances the immunogenicity of the breast cancer cell line MCF-7 upon assistance of TLR2. Wu S; Lu X; Zhang ZL; Lei P; Hu P; Wang M; Huang B; Xing W; Jiang XT; Liu HJ; Zhu ZG; Li WH; Zhu HF; Fu N; Shen GX Carcinogenesis; 2011 Mar; 32(3):296-304. PubMed ID: 21149644 [TBL] [Abstract][Full Text] [Related]
29. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model. Ahn E; Kim H; Han KT; Sin JI Cancer Lett; 2015 Jan; 356(2 Pt B):676-85. PubMed ID: 25449428 [TBL] [Abstract][Full Text] [Related]
30. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses. Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360 [TBL] [Abstract][Full Text] [Related]
31. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand. Kim H; Rhee SH; Pothoulakis C; Lamont JT Gastroenterology; 2007 Sep; 133(3):875-86. PubMed ID: 17854595 [TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones. Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755 [TBL] [Abstract][Full Text] [Related]
33. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression. Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127 [TBL] [Abstract][Full Text] [Related]
34. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. Kikuchi T; Miyazawa N; Moore MA; Crystal RG Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803 [TBL] [Abstract][Full Text] [Related]
36. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Williams NS; Engelhard VH J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456 [TBL] [Abstract][Full Text] [Related]
37. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348 [TBL] [Abstract][Full Text] [Related]
38. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655 [TBL] [Abstract][Full Text] [Related]
39. CD4(+) T cells from food allergy model are resistant to TCR-dependent apoptotic induction. He W; Yang C; Xia L; Zhao MZ; Ge RT; Huang H; Ji Q; Yang PC; Liu Z Cytokine; 2014 Jul; 68(1):32-9. PubMed ID: 24787054 [TBL] [Abstract][Full Text] [Related]
40. Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice. Fischborn SV; Soerensen J; Potschka H Epilepsy Res; 2010 Sep; 91(1):57-65. PubMed ID: 20655707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]